New-look Sarepta eyes approval for muscular dystrophy drug

By Zeba Siddiqui (Reuters) - After three decades without bringing a drug to market, Sarepta Therapeutics Inc stands on the verge of a breakthrough with its treatment for a crippling genetic disorder that affects one in every 3,500 newborn boys. If...

Source: http://health.yahoo.net/news/s/nm/new-look-sarepta-eyes-approval-for-muscular-dystrophy-drug

for more more information more info info